Literature DB >> 8912500

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912500     DOI: 10.1002/art.1780391104

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  42 in total

Review 1.  Rheumatic manifestations of current pharmacopeia.

Authors:  J Brenner; B M Solitar; B D Golden
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

Review 2.  Bone loss and glucocorticoid therapy in patients with respiratory disease.

Authors:  A Fairney
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 3.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 4.  Rheumatology: 11. Evaluation of the patient with pain all over.

Authors:  M P Puttick
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

Review 5.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

6.  Practice patterns in osteoporosis prevention in patients on glucocorticoids.

Authors:  M Naunton; M Duyvendak; G M Peterson; J R B J Brouwers
Journal:  Osteoporos Int       Date:  2006       Impact factor: 4.507

Review 7.  Alendronate: an update of its use in osteoporosis.

Authors:  M Sharpe; S Noble; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 8.  Prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  F Eggelmeijer
Journal:  Pharm World Sci       Date:  1998-10

Review 9.  Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.

Authors:  A D Dick; M Azim; J V Forrester
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

Review 10.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.